Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFranchise Brands Regulatory News (FRAN)

Share Price Information for Franchise Brands (FRAN)

Share Price is delayed by 15 minutes
Get Live Data
142.00    0.00 (0.00%)
Bid:
142.50
Ask:
148.50
Spread: 6.00 (4.211%)
Market Cap: £272.19m
FRAN Live PriceLast checked at - London Stock Exchange

Intraday Franchise Brands Share Chart

EBT share purchase programme update

14 Oct 2025 07:00

RNS Number : 1880D
Franchise Brands PLC
14 October 2025
 

14 October 2025

 

FRANCHISE BRANDS PLC

 

("Franchise Brands", the "Group" or the "Company")

 

EBT share purchase programme update

 

On 15 October 2024, the Company announced the re-commencement of the Employee Benefit Trust ("EBT") share purchase programme up to an aggregate value of £5m. Since then the Company has carried out a regular and consistent programme, with £1.4m funded to date. The programme seeks to mitigate the dilutive impact of share option awards and to improve overall shareholder return.

The EBT currently holds 1.5m Ordinary Shares which represents 0.77 per cent. of the Company's current issued share capital.

Anomalies in the share price present opportunities for the Board to act in the interests of all shareholders to fund the EBT to purchase shares. Given that the Board believes the current share price significantly undervalues the Group, it has decided to fund the EBT to purchase additional shares to an aggregate value of £1m as part of the £5m total.

Due to the limited liquidity in the issued Ordinary Shares, any share purchase of Ordinary Shares pursuant to the authority on any trading day may represent a significant proportion of the daily trading volume in the Ordinary Shares on the London Stock Exchange and may exceed 25 per cent. of the average daily trading volume, being the limit laid down in Article 5(1) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and the Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and, accordingly, the Company will not benefit from the exemption contained in that Article.

 

Enquiries:

Franchise Brands plc

+ 44 (0) 1625 813231

Stephen Hemsley, Executive Chairman

Peter Molloy, CEO

Andrew Mallows, CFO

Julia Choudhury, Corporate Development Director

Stifel Nicolaus Europe Limited (Nominated Adviser and Joint Broker)

+44 (0) 20 7710 7600

Matthew Blawat

Jason Grossman

 

Allenby Capital Limited (Joint Broker)

+44 (0) 20 3328 5656

Jeremy Porter / Daniel Dearden-Williams (Corporate Finance)

Amrit Nahal / Joscelin Pinnington (Sales & Corporate Broking)

Dowgate Capital Limited (Joint Broker)

+44 (0) 20 3903 7715

James Serjeant/Amber Higgs (Corporate Broking)

Mel Brown (Sales)

MHP Group (Financial PR)

+44 (0) 20 3128 8100

Katie Hunt / Hugo Harris

+44 (0) 7884 494112

franchisebrands@mhpgroup.com

 

About Franchise Brands plc

Franchise Brands (FTSE AIM UK 50) is an international, multi-brand franchisor focused on B2B van-based service with seven franchise brands and a presence in 10 countries across the UK, North America and Europe. The Group is focused on building market-leading businesses primarily via a franchise model and has a combined network of c600 franchisees.

The Company owns several market-leading brands with long trading histories, including Pirtek in Europe, Filta, Metro Rod and Metro Plumb, all of which benefit from the Group's central support services, particularly technology, marketing, and finance. At the heart of Franchise Brands' business-building strategy is helping its franchisees grow their businesses: "as they grow, we grow".

Franchise Brands employs over 625 people across the Group and there are over 3,000 people in the franchise community.

For further information, visit www.franchisebrands.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSVXLFFEBLFFBV
Date   Source Headline
26th May 202612:58 pmRNSGrant of Options to director
18th May 20267:00 amRNSAppointment of new CFO & Group Delivery Director
30th Apr 20264:01 pmRNSResult of General Meeting
30th Apr 20264:00 pmRNSResult of Annual General Meeting
30th Apr 20267:00 amRNSAGM Statement and Q1 Trading Update
7th Apr 202612:29 pmRNSHolding(s) in Company
31st Mar 20265:13 pmRNSProposed Share Premium cancellation
31st Mar 20265:13 pmRNSAnnual Report and Accounts & Notice of AGM
27th Mar 20267:00 amRNSGrant of Options to directors
27th Mar 20267:00 amRNSDirectors’ dealings
26th Mar 20267:00 amRNSDirectors' dealings
25th Mar 20267:00 amRNSFinal Results
18th Mar 20267:00 amRNS-RInvestor Presentation via Investor Meet Company
11th Mar 20263:13 pmRNSHolding(s) in Company
11th Mar 20263:13 pmRNSHolding(s) in Company
5th Mar 202611:17 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSNotice of Results
2nd Mar 20262:00 pmRNSHolding(s) in Company
28th Jan 20267:00 amRNSTrading Update
21st Jan 20263:00 pmRNSHolding(s) in Company
21st Jan 20262:55 pmRNSHolding(s) in Company
12th Jan 20267:00 amRNSHolding(s) in Company
12th Nov 20257:00 amRNSQ3 Trading Update
3rd Nov 20252:00 pmRNSHolding(s) in Company
16th Oct 20257:00 amRNSDirectors’ dealings
14th Oct 20257:00 amRNSEBT share purchase programme update
9th Oct 20253:48 pmRNSDirectors’ dealings – Replacement
9th Oct 20257:00 amRNSDirectors' dealings
1st Oct 20255:00 pmRNSDirectors’ dealings
29th Sep 20256:05 pmRNSDirectors’ dealings
23rd Sep 20252:00 pmRNSHolding(s) in Company
5th Aug 20258:46 amRNSUpdate on potential listing
31st Jul 20251:52 pmRNSGrant of Options to director
30th Jul 20257:00 amRNSInterim Results
21st Jul 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
7th Jul 20257:00 amRNSNotice of Interim Results
23rd Jun 20257:00 amRNS-RInclusion in FTSE AIM UK 50 Index
28th May 202511:06 amRNSHolding(s) in Company
19th May 20257:00 amRNSMove to SETS
7th May 20253:00 pmRNSResult of AGM
7th May 20257:00 amRNSAGM Statement and Q1 Trading Update
9th Apr 202510:00 amRNSDirectors' dealings
8th Apr 202510:00 amRNSDirectors' dealings
7th Apr 202510:00 amRNSDirectors’ dealings
4th Apr 20254:00 pmRNSHolding(s) in Company
2nd Apr 20259:00 amRNS-RInvestor Presentation via Investor Meet Company
1st Apr 20252:19 pmRNSAnnual Report and Accounts & Notice of AGM
31st Mar 202510:30 amRNSDirector/PDMR Shareholding
27th Mar 20257:00 amRNSFinal Results
17th Mar 20257:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.